Firstly, large-scale drug screening (130 compounds) in >600 human cancer cell lines identified a highly significant association between EWS-FLI1, the hallmark translocation of Ewing sarcoma, and sensitivity to the olaparib. The gene discussed is EWSR1; the disease is Ewing sarcoma.